Healthcare · Drug Manufacturers - Specialty & Generic
Price
$9.24
Market Cap
$40.8B
Employees
24,561
Beta
0.25
Avg Volume
8,987,150
CEO
Brian James McNamara
Business Description
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
APIStock Price / EPS (Diluted)
30.42
Stock Price: $9.24
EPS (Diluted): 0.36
EPS (Diluted): 0.36
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
2.05
Stock Price: $9.24
Total Equity: $16.40B
Shares: 4,505,585,000
Total Equity: $16.40B
Shares: 4,505,585,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
18.34
Market Cap: $40.79B
Total Debt: $8.50B
Cash: $1.32B
EBITDA: $2.88B
Total Debt: $8.50B
Cash: $1.32B
EBITDA: $2.88B
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$40.9B
Market Cap: $40.79B
Total Debt: $8.50B
Cash: $1.32B
Total Debt: $8.50B
Cash: $1.32B
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
63.3%
Gross Profit: $6.99B
Revenue: $11.03B
Revenue: $11.03B
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
21.9%
Operating Income: $2.41B
Revenue: $11.03B
Revenue: $11.03B
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
14.8%
Net Income: $1.63B
Revenue: $11.03B
Revenue: $11.03B
ROE (Profit from shareholder equity)
APINet Income / Total Equity
6.4%
Net Income: $1.63B
Total Equity: $16.40B
Total Equity: $16.40B
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
4.1%
Operating Income: $2.41B
Tax Rate: 21.5%
Equity: $16.40B
Total Debt: $8.50B
Cash: $1.32B
Tax Rate: 21.5%
Equity: $16.40B
Total Debt: $8.50B
Cash: $1.32B
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
0.92
Current Assets: $4.54B
Current Liabilities: $4.92B
Current Liabilities: $4.92B
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.52
Short-Term Debt: $834.53M
Long-Term Debt: $7.66B
Total Debt: $8.50B
Total Equity: $16.40B
Long-Term Debt: $7.66B
Total Debt: $8.50B
Total Equity: $16.40B
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$2.45
Revenue: $11.03B
Shares: 4,505,585,000
Shares: 4,505,585,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$3.64
Total Equity: $16.40B
Shares: 4,505,585,000
Shares: 4,505,585,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$0.44
Operating CF: $2.29B
CapEx: -$314.94M
Shares: 4,505,585,000
CapEx: -$314.94M
Shares: 4,505,585,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
1.8%
Last Dividend: N/A
Stock Price: $9.24
Stock Price: $9.24
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $1.63B
Net Income: $1.63B
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares HLN against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 7:01pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $9.5B | $10.9B | $11.3B | $11.2B | $11.0B |
| Cost of Revenue | $3.6B | $4.3B | $4.3B | $4.3B | $3.8B |
| Gross Profit | $6.0B | $6.6B | $7.0B | $6.9B | $7.0B |
| Operating Expenses | $4.3B | $4.8B | $5.0B | $4.7B | $4.4B |
| Operating Income | $1.6B | $1.8B | $2.0B | $2.2B | $2.4B |
| Net Income | $1.4B | $1.1B | $1.0B | $1.4B | $1.6B |
| EBITDA | $2.2B | $2.2B | $2.4B | $2.5B | $2.9B |
| EPS | $0.30 | $0.24 | $0.24 | $0.32 | $0.36 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:01pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $414.0M | $684.0M | $1.0B | $2.2B | $1.3B |
| Total Current Assets | $5.3B | $4.1B | $4.8B | $5.7B | $4.5B |
| Total Assets | $34.5B | $34.8B | $34.1B | $34.3B | $32.6B |
| Current Liabilities | $4.2B | $4.4B | $4.6B | $5.8B | $4.9B |
| Long-Term Debt | $1.0M | $9.9B | $8.7B | $8.5B | $7.7B |
| Total Liabilities | $8.0B | $18.4B | $17.3B | $18.1B | $16.1B |
| Total Equity | $26.4B | $16.3B | $16.6B | $16.2B | $16.4B |
| Retained Earnings | $38.0B | $26.7B | $27.5B | $27.3B | $16.1B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:01pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $2.1B | $2.1B | $2.3B | $2.3B |
| Capital Expenditure | -$298.0M | -$328.0M | -$336.0M | -$250.0M | -$314.9M |
| Free Cash Flow | $1.1B | $1.7B | $1.8B | $2.1B | $2.0B |
| Acquisitions (net) | $112.0M | $9.2B | -$71.0M | $0 | -$157.5M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | -$38.0M | -$121.0M | -$639.7M |
| Net Change in Cash | $82.0M | $205.0M | $383.0M | $1.2B | -$769.7M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:48am (1h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$12.1B $12.0B – $12.2B
|
$12.6B $12.5B – $12.8B
|
$13.1B $13.0B – $13.3B
|
$13.6B $13.4B – $13.7B
|
| EBITDA |
$3.6B $3.6B – $3.7B
|
$3.8B $3.7B – $3.8B
|
$3.9B $3.9B – $4.0B
|
$4.1B $4.0B – $4.1B
|
| Net Income |
$2.1B $2.0B – $2.1B
|
$2.3B $2.2B – $2.5B
|
$2.5B $2.4B – $2.5B
|
$2.6B $2.5B – $2.6B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:01pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +13.8% | +4.1% | -0.6% | -1.8% |
| Gross Profit Growth | +10.5% | +5.8% | -0.2% | +0.6% |
| Operating Income Growth | +11.4% | +9.4% | +10.5% | +9.3% |
| Net Income Growth | -23.7% | -1.0% | +37.5% | +13.1% |
| EBITDA Growth | -1.3% | +7.7% | +6.9% | +14.5% |
Dividend History (Last 20)
Last updated: Jun 21, 2026 7:01pm (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-04-10 | $0.13 | 2026-02-25 | 2026-04-10 | 2026-05-14 |
| 2025-08-15 | $0.06 | 2025-08-04 | 2025-08-15 | 2025-09-18 |
| 2025-04-25 | $0.12 | 2025-02-27 | 2025-04-25 | 2025-06-05 |
| 2024-08-16 | $0.05 | 2024-08-01 | 2024-08-16 | 2024-09-19 |
| 2024-03-14 | $0.11 | 2024-02-29 | 2024-03-15 | 2024-05-16 |
| 2023-08-24 | $0.05 | 2023-08-02 | 2023-08-25 | 2023-10-05 |
| 2023-03-16 | $0.06 | 2023-03-02 | 2023-03-17 | 2023-04-27 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for HLN — it's generated by the pipeline (
market-narrative step).
No community reviews yet for HLN.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30